DE69426317D1 - Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation - Google Patents

Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation

Info

Publication number
DE69426317D1
DE69426317D1 DE69426317T DE69426317T DE69426317D1 DE 69426317 D1 DE69426317 D1 DE 69426317D1 DE 69426317 T DE69426317 T DE 69426317T DE 69426317 T DE69426317 T DE 69426317T DE 69426317 D1 DE69426317 D1 DE 69426317D1
Authority
DE
Germany
Prior art keywords
beta
platelet aggregation
naphthoquinone derivatives
inhibit platelet
naphthoquinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69426317T
Other languages
English (en)
Other versions
DE69426317T2 (de
Inventor
Denis Blache
Christian Bloy
Bernard Hercelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Hoechst Marion Roussel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel filed Critical Hoechst Marion Roussel
Publication of DE69426317D1 publication Critical patent/DE69426317D1/de
Application granted granted Critical
Publication of DE69426317T2 publication Critical patent/DE69426317T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69426317T 1993-07-02 1994-06-28 Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation Expired - Lifetime DE69426317T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308112A FR2707495B1 (fr) 1993-07-02 1993-07-02 Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.

Publications (2)

Publication Number Publication Date
DE69426317D1 true DE69426317D1 (de) 2000-12-28
DE69426317T2 DE69426317T2 (de) 2001-05-03

Family

ID=9448828

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426317T Expired - Lifetime DE69426317T2 (de) 1993-07-02 1994-06-28 Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation

Country Status (13)

Country Link
US (1) US5523322A (de)
EP (1) EP0631777B1 (de)
JP (1) JP3993646B2 (de)
AT (1) ATE197669T1 (de)
CA (1) CA2127215C (de)
DE (1) DE69426317T2 (de)
DK (1) DK0631777T3 (de)
ES (1) ES2154286T3 (de)
FR (1) FR2707495B1 (de)
GR (1) GR3035058T3 (de)
HU (1) HU214058B (de)
PT (1) PT631777E (de)
RU (1) RU2122853C1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011151A3 (fr) * 1997-05-13 1999-05-04 Jose Remacle Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie.
FR2796552A1 (fr) * 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR924M (de) * 1959-09-26 1961-11-13

Also Published As

Publication number Publication date
CA2127215C (fr) 2004-10-26
RU2122853C1 (ru) 1998-12-10
DK0631777T3 (da) 2001-03-05
EP0631777B1 (de) 2000-11-22
US5523322A (en) 1996-06-04
FR2707495B1 (fr) 1995-09-01
HU214058B (en) 1997-12-29
PT631777E (pt) 2001-05-31
ATE197669T1 (de) 2000-12-15
JP3993646B2 (ja) 2007-10-17
CA2127215A1 (fr) 1995-01-03
EP0631777A1 (de) 1995-01-04
HUT70508A (en) 1995-10-30
DE69426317T2 (de) 2001-05-03
JPH07145128A (ja) 1995-06-06
HU9401978D0 (en) 1994-09-28
FR2707495A1 (fr) 1995-01-20
ES2154286T3 (es) 2001-04-01
GR3035058T3 (en) 2001-03-30
RU94022757A (ru) 1996-09-27

Similar Documents

Publication Publication Date Title
ATE175669T1 (de) Sulfonylaminopyrimidine, ihre herstellung und verwendung als heilmittel
DK0530505T3 (da) Hydantoinderivater
FI940072A (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
DE59407431D1 (de) Verwendung aromatischer Carbonsäurederivate zur Herstellung von pharmazeutischen Präparaten
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE58906387D1 (de) Verwendung von Benzimidazolen zur Herstellung eines Arzneimittels mit antiischämischen Wirkungen am Herzen und dessen Kombinationen mit Beta-Blockern oder Bradycardica.
ATE132861T1 (de) Derivate von hexahydroazepine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATE57095T1 (de) Verwendung von hydroxyindolderivaten zur herstellung eines arzneimittels zur senkung des blutdrucks.
DE69426317T2 (de) Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation
DE69426316D1 (de) Verwendung von Beta-Naphthochinonderivaten zur Beschleunigung der Proliferation der Endothelzellen und Inhibierung der NO-Synthasen
YU47723B (sh) Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina
ES8605247A1 (es) Procedimiento para la obtencion de arisulfonilguanidinas sustituidas
ES455832A1 (es) Procedimientos para la preparacion de derivados de la pipe- ridina.
DE69402241D1 (de) Verwendung von 2-Acetylpyridine zur Herstellung eines Arzneimittles zur Unterdrückung des Rauchens
ATE74354T1 (de) N-karbethoxy-4-thiazolin-karbonsaeure, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69103025D1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl-benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.
GR3024709T3 (en) Novel cytarabine derivatives, their production and use

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS PHARMA S.A., ANTONY, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC